rocuronium
Study Finds Rocuronium Results in Shorter Intubation Onset Times in Older Patients
When it comes to intubating patients who are at least 80 years of age, a 0.9-mg/kg dose of rocuronium results in ...
NOVEMBER 3, 2022
Factors Increasing Need for Additional Reversal in Peds Described
Researchers have identified a series of risk factors for residual neuromuscular blockade after rocuronium ...
MAY 20, 2022
Reversal of Deep Rocuronium Blocks Faster With Sugammadex Than Neostigmine
Sugammadex reverses deep rocuronium neuromuscular blocks significantly faster than neostigmine reverses a moderate ...
SEPTEMBER 21, 2021
Neuromuscular Block Protocol Decreases Residual Blockade
Use of rocuronium, neostigmine and sugammadex is linked to low incidence of post-op residual neuromuscular ...
MARCH 23, 2020
Keeping Patients Safe From Residual Neuromuscular Blockade: The Case for Lower-Dose Sugammadex
Sugammadex (Bridion, Merck) has proven to be superior to acetylcholinesterase inhibitors for the reversal of ...
NOVEMBER 8, 2018
